TAMBOCOR

This brand name is authorized in Australia, Germany, Ecuador, Estonia, Finland, Hong Kong, Ireland, Israel, Japan, Malta, Mexico, Netherlands, New Zealand, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug TAMBOCOR contains one active pharmaceutical ingredient (API):

1 Flecainide UNII M8U465Q1WQ - FLECAINIDE ACETATE

Flecainide acetate is a Class IC antiarrhythmic agent used for the treatment of severe symptomatic life-threatening ventricular arrhythmias and supraventricular arrhythmias. Electrophysiologically, flecainide is a local anaesthetic-type (Class IC) of antiarrhythmic compound. It is an amide type of local anaesthetic, being structurally related to procainamide and encainide in so far as these agents are also benzamide derivatives. Read about Flecainide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01BC04	Flecainide	C Cardiovascular system → C01 Cardiac therapy → C01B Antiarrhythmics, class I and III → C01BC Antiarrhythmics, class Ic
Discover more medicines within C01BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1088G, 1090J
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 01416671, 02489761, 02489778, 02489784, 03837098, 03837106, 04355378, 04355384, 04355390, 04921027, 04965941, 04965958, 13331916, 13515651, 13899798, 17638385
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 4446-MEE-1018
Country: EE	Ravimiamet	Identifier(s): 1032231, 1032242, 1032253, 1070626, 1070637, 1421806, 1695168, 1756942
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 009146, 009490, 068437, 068445, 068452
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 14006, 162620
Country: HK	Department of Health Drug Office	Identifier(s): 24395, 60853, 60854
Country: IE	Health Products Regulatory Authority	Identifier(s): 49077, 49093
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 2869, 4189, 7300
Country: JP	医薬品医療機器総合機構	Identifier(s): 2129009C1023, 2129009F1020, 2129009F2026, 2129406A1030
Country: MT	Medicines Authority	Identifier(s): AA565/65304, AA729/30901, MA1507/02001
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 009M84
Country: NL	Z-Index G-Standaard	Identifier(s): 13882252
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 19712, 20419, 38253, 67237, 67245, 67253, 70661
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 4069, 4070, 4071, 4072, 4074, 4075
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68727001, W68727002, W68727003, W68728001, W68728002, W68728003
Country: SG	Health Sciences Authority	Identifier(s): 01726P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/6.2/0198, 37/6.2/0199, 37/6.2/0200, 37/6.2/0201, S/6.2/16, S/6.2/17